Internal Medicine, Rheumatology · San Antonio, TX
NPI
1285644427
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4511 Horizon Hill Blvd, Suite 150
San Antonio, TX, 78229
Phone (210) 477-2626
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
199,015 services
Medicare patients, 2024
739
Average age 73
Drug cost, 2024
$5.8M
4,654 prescriptions
Company payments, 2025
$1,428
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose F Roldan was code J3262 (injection, tocilizumab, 1 mg), 91,808 times for 24 patients. In total Jose F Roldan billed 199,015 services in 102 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 91,808 | 24 | $4.67 | $428K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 15,575 | 24 | $33.71 | $525K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,600 | 14 | $8.94 | $95K |
| J0897 Injection, denosumab, 1 mg | Office | 9,431 | 101 | $20.20 | $191K |
| J9312 Injection, rituximab, 10 mg | Office | 9,109 | 30 | $61.23 | $558K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,017 | 54 | $0.10 | $396 |
| 99214 Office E&M - Established | Office | 1,852 | 695 | $86.22 | $160K |
| 86235 Immunoassay | Office | 1,530 | 184 | $17.22 | $26K |
| 36415 Venipuncture Blood Collection | Office | 1,362 | 526 | $5.74 | $7,815 |
| 85651 Clinical Chemistry | Office | 1,152 | 468 | $4.07 | $4,690 |
| 86140 Clinical Chemistry | Office | 1,151 | 468 | $4.95 | $5,695 |
| 85025 Blood Count | Office | 1,151 | 457 | $7.41 | $8,533 |
| 80053 Clinical Chemistry | Office | 1,123 | 449 | $10.07 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 904 | 526 | $11.36 | $10K |
| 96413 Chemotherapy Administration | Office | 601 | 102 | $95.47 | $57K |
By year: 2022 $2.2M for 171,973 services; 2023 $2.4M for 198,563 services; 2024 $2.6M for 199,015 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 1,530 | 184 | $17.22 | $26K |
| 36415 Venipuncture Blood Collection | 1,362 | 526 | $5.74 | $7,815 |
| 85651 Clinical Chemistry | 1,152 | 468 | $4.07 | $4,690 |
| 86140 Clinical Chemistry | 1,151 | 468 | $4.95 | $5,695 |
| 85025 Blood Count | 1,151 | 457 | $7.41 | $8,533 |
| 80053 Clinical Chemistry | 1,123 | 449 | $10.07 | $11K |
| 82306 Clinical Chemistry | 476 | 371 | $28.71 | $14K |
| 83516 Immunoassay | 320 | 159 | $11.10 | $3,552 |
| 86160 Immunoassay | 212 | 194 | $11.49 | $2,436 |
| 86225 Immunoassay | 189 | 184 | $13.20 | $2,494 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose F Roldan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,476 prescriptions and refills. In total Jose F Roldan wrote 4,654 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,476 | 3,332 | 460 | $54K |
| Methotrexate Methotrexate Sodium | 451 | 749 | 144 | $9,098 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 235 | 235 | 47 | $8,476 |
| Prednisone Generic | 223 | 293 | 64 | $1,482 |
| Mycophenolate Mofetil Generic | 165 | 280 | 53 | $13K |
| Humira(Cf) Pen Adalimumab | 121 | 122 | 20 | $902K |
| Orencia Clickject Abatacept | 110 | 114 | 14 | $666K |
| Ibandronate Sodium Generic | 104 | 298 | 40 | $8,302 |
| Methylprednisolone Generic | 97 | 97 | 75 | $778 |
| Rinvoq Upadacitinib | 83 | 96 | 13 | $587K |
| Leflunomide Generic | 82 | 138 | 26 | $3,191 |
| Enbrel Sureclick Etanercept | 74 | 79 | 15 | $718K |
| Folic Acid Generic | 70 | 142 | 32 | $368 |
| Mycophenolic Acid Mycophenolate Sodium | 65 | 91 | 19 | $13K |
| Celecoxib Generic | 60 | 125 | 20 | $1,809 |
Brand drugs: - claims; generic drugs: 3,790 claims; opioid claims: 329.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose F Roldan $1,428 ($1,428 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novartis Pharmaceuticals Corporation with $328.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $328 |
| GlaxoSmithKline, LLC. GSK | 20 | $298 |
| Amgen Inc. AMGN | 23 | $260 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $191 |
| Janssen Biotech, Inc. JNJ | 24 | $148 |
| UCB, Inc. UCB.BR | 4 | $57.98 |
| Grifols USA, LLC | 2 | $39.03 |
| Medtronic, Inc. MDT | 1 | $37.42 |
| Almatica Pharma LLC | 1 | $22.99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.